EPZM

Epizyme, Inc.CIK 1571498 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for EPZM PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for EPZM

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Stuckley Carol	Director	5	$0	$0	2022-08-12
Richon Victoria	Director	8	$0	$0	2022-08-12
Beaulieu Joseph	See Remarks	30	$0	$64.2K	2022-08-12
Agarwal Shefali	See Remarks	41	$0	$255.7K	2022-08-12
Giordano Michael F	Director	9	$0	$0	2022-08-12
Kutok Jeffery	Chief Scientific Officer	15	$0	$23.8K	2022-08-12
Bogle Grant C.	See Remarks	17	$0	$0	2022-08-12
BEVERIDGE, ROY A	Director	8	$0	$0	2022-08-12
Legorreta Pablo G.	Director, 10% Owner	7	$0	$0	2022-08-12
Conroy Kevin T	Director	25	$0	$0	2022-08-12
MOTT DAVID M	Director, 10% Owner	61	$32.29M	$2.02M	2022-08-12
BATE KENNETH	Director	13	$0	$0	2022-08-12
GOLDFISCHER CARL	Director, 10% Owner	37	$7.56M	$33.28M	2022-08-12
Korn Jerald	Chief Operating Officer	1	$0	$0	2022-04-01
RPI Finance Trust	Director, 10% Owner	3	$34.00M	$0	2022-01-31
Ros Matthew	See Remarks	37	$0	$3.75M	2021-08-16
Allen Andrew R	Director	11	$0	$0	2021-06-11
Bazemore Robert B	President & CEO	33	$0	$984.4K	2021-03-25
Vakiener Victoria	Chief Commercial Officer	4	$0	$16.0K	2021-02-04
TOMBESI PAOLO	Chief Financial Officer	17	$0	$59.6K	2021-02-04
POPS RICHARD F	Director	8	$0	$0	2020-05-29
RP Management, LLC	Director, 10% Owner	1	$0	$0	2020-02-11
SEIDENBERG BETH C	Director, 10% Owner	16	$0	$10.74M	2019-06-30
Fleming Suzanne	SVP	2	$0	$0	2018-02-09
Graf Susan E	Chief Business Officer	3	$0	$0	2018-02-09
Ho Peter Tai-Ching	Chief Development Officer	37	$135.7K	$1.40M	2017-10-24
Singer Andrew E.	EVP & CFO	105	$0	$325.4K	2017-08-09
Copeland Robert A	President of Research and CSO	107	$0	$8.03M	2017-06-06
Viswanathan Ravi	10% Owner	14	$24.00M	$15.4K	2016-01-12
NEW ENTERPRISE ASSOCIATES 13 LP	10% Owner	10	$24.00M	$0	2016-01-12
Bay City Capital Fund V Co-Investment Fund, L.P.	10% Owner	11	$7.50M	$13.65M	2016-01-12
Weller Harry R	10% Owner	18	$24.00M	$0	2016-01-12
BASKETT FOREST	10% Owner	17	$24.00M	$145.2K	2016-01-12
KOLLURI KRISHNA KITTU	10% Owner	27	$24.00M	$47.6K	2016-01-12
SANDELL SCOTT D	10% Owner	16	$24.00M	$124.5K	2016-01-12
KERINS PATRICK J	10% Owner	13	$24.00M	$0	2016-01-12
BARRETT M JAMES	10% Owner	19	$24.00M	$147.8K	2016-01-12
BARRIS PETER J	10% Owner	17	$24.00M	$124.5K	2016-01-12
Gould Robert J	President and CEO	64	$0	$13.16M	2015-12-30
Garbacz Stephen	Principal Accounting Officer	9	$0	$62.5K	2014-11-03
Hedrick Eric	Chief Medical Officer	19	$0	$691.7K	2014-10-15
Rhodes Jason P	President, CFO and Treasurer	46	$0	$6.36M	2014-09-22
BAY CITY CAPITAL LLC	10% Owner	10	$0	$19.49M	2014-08-26
DRANT RYAN D	10% Owner	18	$14.00M	$148.4K	2014-08-15
NEA Partners 13, Limited Partnership	10% Owner	3	$0	$0	2014-08-14
Celgene European Investment Co LLC	10% Owner	4	$10.94M	$0	2014-02-10
KLEINER PERKINS CAUFIELD & BYERS XIII, LLC	10% Owner	1	$0	$10.74M	2014-02-10
MPM BioVentures IV LLC	10% Owner	1	$0	$13.65M	2014-02-10
GADICKE ANSBERT	10% Owner	1	$0	$13.65M	2014-02-10
Amgen Ventures LLC	10% Owner	3	$250.0K	$0	2013-06-05
Shiosaki Kazumi	Director	1	$0	$0	2013-06-05
Astellas Venture Fund I L.P.	10% Owner	3	$230.0K	$0	2013-06-05
KPCB XIII Associates, LLC	10% Owner	4	$0	$0	2013-06-05
Vander Vort John	10% Owner	4	$0	$0	2013-06-05
EVNIN LUKE	10% Owner	4	$0	$0	2013-06-05

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Legorreta Pablo G.	Director, 10% Owner	D To issuer deriv	2022-08-12	2022-08-16	8,994	—	$0	0	SEC↗
Legorreta Pablo G.	Director, 10% Owner	D To issuer deriv	2022-08-12	2022-08-16	8,060	—	$0	0	SEC↗
Bogle Grant C.	President and CEO	D To issuer	2022-08-12	2022-08-16	84,170	—	$0	175,000	SEC↗
Bogle Grant C.	President and CEO	D To issuer	2022-08-12	2022-08-16	175,000	—	$0	0	SEC↗
Stuckley Carol	Director	D To issuer	2022-08-12	2022-08-16	25,696	—	$0	0	SEC↗
Kutok Jeffery	Chief Scientific Officer	D To issuer	2022-08-12	2022-08-16	81,021	—	$0	0	SEC↗
Kutok Jeffery	Chief Scientific Officer	D To issuer	2022-08-12	2022-08-16	39,046	—	$0	81,021	SEC↗
BATE KENNETH	Director	D To issuer	2022-08-12	2022-08-16	8,060	—	$0	8,994	SEC↗
BATE KENNETH	Director	D To issuer	2022-08-12	2022-08-16	8,994	—	$0	0	SEC↗
Beaulieu Joseph	See Remarks	D To issuer	2022-08-12	2022-08-16	21,895	—	$0	0	SEC↗
Beaulieu Joseph	See Remarks	D To issuer	2022-08-12	2022-08-16	30,181	—	$0	21,895	SEC↗
Legorreta Pablo G.	Director, 10% Owner	U Tender	2022-08-12	2022-08-16	31,933,334	—	$0	0	SEC↗
Agarwal Shefali	Other	D To issuer	2022-08-12	2022-08-16	107,292	—	$0	0	SEC↗
Agarwal Shefali	Other	D To issuer	2022-08-12	2022-08-16	179,247	—	$0	107,292	SEC↗
BEVERIDGE, ROY A	Director	D To issuer	2022-08-12	2022-08-16	25,696	—	$0	0	SEC↗
BEVERIDGE, ROY A	Director	D To issuer	2022-08-12	2022-08-16	20,341	—	$0	25,696	SEC↗
MOTT DAVID M	Director	U Tender	2022-08-12	2022-08-16	106,959	—	$0	0	SEC↗
MOTT DAVID M	Director	U Tender	2022-08-12	2022-08-16	215,494	—	$0	8,994	SEC↗
MOTT DAVID M	Director	D To issuer	2022-08-12	2022-08-16	8,994	—	$0	0	SEC↗
Richon Victoria	Director	D To issuer	2022-08-12	2022-08-16	13,614	—	$0	8,994	SEC↗
Richon Victoria	Director	D To issuer	2022-08-12	2022-08-16	8,994	—	$0	0	SEC↗
Conroy Kevin T	Director	D To issuer	2022-08-12	2022-08-16	8,994	—	$0	0	SEC↗
Conroy Kevin T	Director	D To issuer	2022-08-12	2022-08-16	53,324	—	$0	8,994	SEC↗
GOLDFISCHER CARL	Director	D To issuer	2022-08-12	2022-08-16	8,994	—	$0	0	SEC↗
GOLDFISCHER CARL	Director	D To issuer	2022-08-12	2022-08-16	13,060	—	$0	8,994	SEC↗
GOLDFISCHER CARL	Director	D To issuer	2022-08-12	2022-08-16	3,380,951	—	$0	0	SEC↗
Giordano Michael F	Director	D To issuer	2022-08-12	2022-08-16	8,994	—	$0	0	SEC↗
Giordano Michael F	Director	D To issuer	2022-08-12	2022-08-16	8,060	—	$0	8,994	SEC↗
Kutok Jeffery	Chief Scientific Officer	M Exercise deriv	2022-08-09	2022-08-11	380,000	—	$0	0	SEC↗
Beaulieu Joseph	See Remarks	M Exercise deriv	2022-08-09	2022-08-11	300,000	—	$0	0	SEC↗
Agarwal Shefali	Other	M Exercise deriv	2022-08-09	2022-08-11	56,527	—	$0	443,473	SEC↗
Agarwal Shefali	Other	M Exercise deriv	2022-08-09	2022-08-11	43,473	—	$0	400,000	SEC↗
Agarwal Shefali	Other	M Exercise deriv	2022-08-09	2022-08-11	400,000	—	$0	0	SEC↗
Bogle Grant C.	See Remarks	M Exercise deriv	2022-08-09	2022-08-11	417,500	—	$0	0	SEC↗
Bogle Grant C.	See Remarks	M Exercise deriv	2022-08-09	2022-08-11	800,000	—	$0	0	SEC↗
Kutok Jeffery	Chief Scientific Officer	F Tax w/h	2022-08-09	2022-08-11	354,496	$1.39	$492.7K	120,067	SEC↗
Kutok Jeffery	Chief Scientific Officer	M Exercise	2022-08-09	2022-08-11	380,000	$1.39	$528.2K	474,563	SEC↗
Beaulieu Joseph	See Remarks	F Tax w/h	2022-08-09	2022-08-11	279,864	$1.39	$389.0K	51,099	SEC↗
Beaulieu Joseph	See Remarks	M Exercise	2022-08-09	2022-08-11	300,000	$1.39	$417.0K	330,963	SEC↗
Agarwal Shefali	Other	F Tax w/h	2022-08-09	2022-08-11	373,154	$1.39	$518.7K	285,562	SEC↗
Agarwal Shefali	Other	M Exercise	2022-08-09	2022-08-11	400,000	$1.39	$556.0K	658,716	SEC↗
Agarwal Shefali	Other	M Exercise	2022-08-09	2022-08-11	43,473	$1.39	$60.4K	258,716	SEC↗
Agarwal Shefali	Other	M Exercise	2022-08-09	2022-08-11	56,527	$1.39	$78.6K	215,243	SEC↗
Bogle Grant C.	See Remarks	M Exercise	2022-08-09	2022-08-11	800,000	$1.39	$1.11M	983,060	SEC↗
Bogle Grant C.	See Remarks	F Tax w/h	2022-08-09	2022-08-11	746,307	$1.39	$1.04M	236,753	SEC↗
Bogle Grant C.	See Remarks	M Exercise	2022-08-09	2022-08-11	417,500	$1.41	$588.7K	654,253	SEC↗
Bogle Grant C.	See Remarks	F Tax w/h	2022-08-09	2022-08-11	395,083	$1.41	$557.1K	259,170	SEC↗
Conroy Kevin T	Director	A Award	2022-06-30	2022-07-05	10,204	$1.47	$15.0K	62,318	SEC↗
BEVERIDGE, ROY A	Director	A Award	2022-06-30	2022-07-05	8,928	$1.47	$13.1K	46,037	SEC↗
MOTT DAVID M	Director	A Award	2022-06-30	2022-07-05	16,156	$1.47	$23.7K	224,488	SEC↗
BEVERIDGE, ROY A	Director	A Award deriv	2022-05-17	2022-05-19	41,006	—	$0	41,006	SEC↗
GOLDFISCHER CARL	Director	A Award deriv	2022-05-17	2022-05-19	41,006	—	$0	41,006	SEC↗
Conroy Kevin T	Director	A Award deriv	2022-05-17	2022-05-19	41,006	—	$0	41,006	SEC↗
MOTT DAVID M	Director	A Award deriv	2022-05-17	2022-05-19	41,006	—	$0	41,006	SEC↗
Giordano Michael F	Director	A Award deriv	2022-05-17	2022-05-19	41,006	—	$0	41,006	SEC↗
Stuckley Carol	Director	A Award deriv	2022-05-17	2022-05-19	41,006	—	$0	41,006	SEC↗
Richon Victoria	Director	A Award deriv	2022-05-17	2022-05-19	41,006	—	$0	41,006	SEC↗
BATE KENNETH	Director	A Award deriv	2022-05-17	2022-05-19	41,006	—	$0	41,006	SEC↗
Legorreta Pablo G.	Director, 10% Owner	A Award deriv	2022-05-17	2022-05-19	41,006	$0.56	$23.0K	41,006	SEC↗
Legorreta Pablo G.	Director, 10% Owner	A Award deriv	2022-05-17	2022-05-19	8,994	—	$0	8,994	SEC↗
BEVERIDGE, ROY A	Director	A Award	2022-05-17	2022-05-19	8,994	—	$0	37,109	SEC↗
GOLDFISCHER CARL	Director	A Award	2022-05-17	2022-05-19	8,994	—	$0	22,054	SEC↗
Conroy Kevin T	Director	A Award	2022-05-17	2022-05-19	8,994	—	$0	52,114	SEC↗
MOTT DAVID M	Director	A Award	2022-05-17	2022-05-19	8,994	—	$0	208,332	SEC↗
Giordano Michael F	Director	A Award	2022-05-17	2022-05-19	8,994	—	$0	17,054	SEC↗
Stuckley Carol	Director	A Award	2022-05-17	2022-05-19	8,994	—	$0	25,696	SEC↗
Richon Victoria	Director	A Award	2022-05-17	2022-05-19	8,994	—	$0	22,608	SEC↗
BATE KENNETH	Director	A Award	2022-05-17	2022-05-19	8,994	—	$0	17,054	SEC↗
Kutok Jeffery	Chief Scientific Officer	S Sale	2022-04-11	2022-04-13	2,741	$0.90	$2.5K	94,563	SEC↗
Korn Jerald	Chief Operating Officer	A Award deriv	2022-04-01	2022-04-04	800,000	—	$0	800,000	SEC↗
Conroy Kevin T	Director	A Award	2022-03-31	2022-04-01	13,043	$1.15	$15.0K	43,120	SEC↗
MOTT DAVID M	Director	A Award	2022-03-31	2022-04-01	20,653	$1.15	$23.8K	199,338	SEC↗
BEVERIDGE, ROY A	Director	A Award	2022-03-31	2022-04-01	11,413	$1.15	$13.1K	28,115	SEC↗
Agarwal Shefali	See Remarks	A Award deriv	2022-03-17	2022-03-21	500,000	—	$0	500,000	SEC↗
Kutok Jeffery	Chief Scientific Officer	A Award deriv	2022-03-17	2022-03-21	380,000	—	$0	380,000	SEC↗
Beaulieu Joseph	See Remarks	A Award deriv	2022-03-17	2022-03-21	300,000	—	$0	300,000	SEC↗
Bogle Grant C.	See Remarks	A Award deriv	2022-03-17	2022-03-21	800,000	—	$0	800,000	SEC↗
Agarwal Shefali	See Remarks	A Award	2022-02-28	2022-03-21	2,331	$1.27	$3.0K	158,716	SEC↗
Beaulieu Joseph	See Remarks	A Award	2022-02-28	2022-03-21	2,331	$1.27	$3.0K	30,963	SEC↗
Agarwal Shefali	See Remarks	S Sale	2022-02-07	2022-02-09	1,058	$1.50	$1.6K	156,385	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2022-02-07	2022-02-09	222	$1.50	$333	28,632	SEC↗
Bogle Grant C.	See Remarks	A Award deriv	2022-02-02	2022-02-04	417,500	—	$0	417,500	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2022-02-02	2022-02-04	687	$1.37	$941	28,854	SEC↗
Kutok Jeffery	Chief Scientific Officer	S Sale	2022-02-02	2022-02-04	2,556	$1.37	$3.5K	97,304	SEC↗
Bogle Grant C.	See Remarks	A Award	2022-02-02	2022-02-04	87,500	—	$0	183,060	SEC↗
Agarwal Shefali	See Remarks	S Sale	2022-02-02	2022-02-04	2,639	$1.37	$3.6K	157,443	SEC↗
RPI Finance Trust	10% Owner	P Buy	2022-01-31	2022-02-01	22,666,667	$1.50	$34.00M	31,833,334	SEC↗
Agarwal Shefali	See Remarks	S Sale	2022-01-26	2022-01-28	2,922	$2.02	$5.9K	160,082	SEC↗
Conroy Kevin T	Director	A Award	2021-12-31	2022-01-04	6,000	$2.50	$15.0K	30,077	SEC↗
MOTT DAVID M	Director	A Award	2021-12-31	2022-01-04	9,500	$2.50	$23.8K	178,685	SEC↗
Agarwal Shefali	See Remarks	S Sale	2021-12-06	2021-12-07	1,780	$2.93	$5.2K	163,004	SEC↗
Stuckley Carol	Director	A Award deriv	2021-11-16	2021-11-18	83,298	—	$0	83,298	SEC↗
BEVERIDGE, ROY A	Director	A Award deriv	2021-11-16	2021-11-18	83,298	—	$0	83,298	SEC↗
Stuckley Carol	Director	A Award	2021-11-16	2021-11-18	16,702	—	$0	16,702	SEC↗
BEVERIDGE, ROY A	Director	A Award	2021-11-16	2021-11-18	16,702	—	$0	16,702	SEC↗
Conroy Kevin T	Director	A Award	2021-09-30	2021-10-01	2,930	$5.12	$15.0K	24,077	SEC↗
MOTT DAVID M	Director	A Award	2021-09-30	2021-10-01	4,640	$5.12	$23.8K	169,185	SEC↗
Agarwal Shefali	See Remarks	A Award deriv	2021-08-16	2021-08-18	282,270	—	$0	282,270	SEC↗
Bogle Grant C.	See Remarks	A Award deriv	2021-08-16	2021-08-18	417,500	—	$0	417,500	SEC↗
Ros Matthew	See Remarks	A Award deriv	2021-08-16	2021-08-18	134,178	—	$0	134,178	SEC↗
Beaulieu Joseph	Corporate Controller	A Award deriv	2021-08-16	2021-08-18	22,250	—	$0	22,250	SEC↗
Kutok Jeffery	Chief Scientific Officer	A Award deriv	2021-08-16	2021-08-18	218,661	—	$0	218,661	SEC↗
Agarwal Shefali	See Remarks	A Award	2021-08-16	2021-08-18	59,166	—	$0	163,507	SEC↗
Bogle Grant C.	See Remarks	A Award	2021-08-16	2021-08-18	87,500	—	$0	95,560	SEC↗
Ros Matthew	See Remarks	A Award	2021-08-16	2021-08-18	28,125	—	$0	111,313	SEC↗
Beaulieu Joseph	Corporate Controller	A Award	2021-08-16	2021-08-18	14,833	—	$0	28,264	SEC↗
Kutok Jeffery	Chief Scientific Officer	A Award	2021-08-16	2021-08-18	45,832	—	$0	99,860	SEC↗
Conroy Kevin T	Director	A Award	2021-06-30	2021-07-01	1,805	$8.31	$15.0K	21,147	SEC↗
MOTT DAVID M	Director	A Award	2021-06-30	2021-07-01	2,858	$8.31	$23.7K	164,545	SEC↗
Richon Victoria	Director	A Award deriv	2021-06-11	2021-06-15	40,559	—	$0	40,559	SEC↗
GOLDFISCHER CARL	Director	A Award deriv	2021-06-11	2021-06-15	40,559	—	$0	40,559	SEC↗
Conroy Kevin T	Director	A Award deriv	2021-06-11	2021-06-15	40,559	—	$0	40,559	SEC↗
MOTT DAVID M	Director	A Award deriv	2021-06-11	2021-06-15	40,559	—	$0	40,559	SEC↗
Allen Andrew R	Director	A Award deriv	2021-06-11	2021-06-15	40,559	—	$0	40,559	SEC↗
Giordano Michael F	Director	A Award deriv	2021-06-11	2021-06-15	40,559	—	$0	40,559	SEC↗
Bogle Grant C.	Director	A Award deriv	2021-06-11	2021-06-15	40,559	—	$0	40,559	SEC↗
BATE KENNETH	Director	A Award deriv	2021-06-11	2021-06-15	40,559	—	$0	40,559	SEC↗
RPI Finance Trust	Director, 10% Owner	A Award deriv	2021-06-11	2021-06-15	40,559	$8.53	$346.0K	40,559	SEC↗
RPI Finance Trust	Director, 10% Owner	A Award deriv	2021-06-11	2021-06-15	8,060	—	$0	8,060	SEC↗
Richon Victoria	Director	A Award	2021-06-11	2021-06-15	8,060	—	$0	13,614	SEC↗
GOLDFISCHER CARL	Director	A Award	2021-06-11	2021-06-15	8,060	—	$0	13,060	SEC↗
Conroy Kevin T	Director	A Award	2021-06-11	2021-06-15	8,060	—	$0	19,342	SEC↗
MOTT DAVID M	Director	A Award	2021-06-11	2021-06-15	8,060	—	$0	161,687	SEC↗
Allen Andrew R	Director	A Award	2021-06-11	2021-06-15	8,060	—	$0	20,560	SEC↗
Giordano Michael F	Director	A Award	2021-06-11	2021-06-15	8,060	—	$0	8,060	SEC↗
Bogle Grant C.	Director	A Award	2021-06-11	2021-06-15	8,060	—	$0	8,060	SEC↗
BATE KENNETH	Director	A Award	2021-06-11	2021-06-15	8,060	—	$0	8,060	SEC↗
Kutok Jeffery	Chief Scientific Officer	S Sale	2021-04-05	2021-04-07	2,029	$8.80	$17.9K	54,028	SEC↗
MOTT DAVID M	Director	A Award	2021-03-31	2021-04-01	2,727	$8.71	$23.8K	153,627	SEC↗
Conroy Kevin T	Director	A Award	2021-03-31	2021-04-01	1,723	$8.71	$15.0K	11,282	SEC↗
MOTT DAVID M	Director	P Buy	2021-03-26	2021-03-29	217	$7.80	$1.7K	150,900	SEC↗
MOTT DAVID M	Director	P Buy	2021-03-26	2021-03-29	34,269	$7.97	$273.1K	150,683	SEC↗
Bazemore Robert B	President & CEO	S Sale	2021-03-25	2021-03-29	10,328	$7.85	$81.1K	322,626	SEC↗
MOTT DAVID M	Director	P Buy	2021-03-25	2021-03-29	28,231	$7.98	$225.3K	116,414	SEC↗
Vakiener Victoria	Chief Commercial Officer	S Sale	2021-02-04	2021-02-05	817	$11.21	$9.2K	52,685	SEC↗
Ros Matthew	See Remarks	S Sale	2021-02-04	2021-02-05	894	$11.21	$10.0K	83,188	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2021-02-04	2021-02-05	227	$11.21	$2.5K	13,431	SEC↗
TOMBESI PAOLO	Chief Financial Officer	S Sale	2021-02-04	2021-02-05	1,021	$11.21	$11.4K	53,465	SEC↗
Agarwal Shefali	Chief Medical Officer	S Sale	2021-02-04	2021-02-05	969	$11.21	$10.9K	104,341	SEC↗
Bazemore Robert B	President & CEO	S Sale	2021-02-04	2021-02-05	3,890	$11.21	$43.6K	331,977	SEC↗
Kutok Jeffery	Chief Scientific Officer	A Award deriv	2021-02-01	2021-02-02	136,663	—	$0	136,663	SEC↗
Ros Matthew	See Remarks	A Award deriv	2021-02-01	2021-02-02	134,178	—	$0	134,178	SEC↗
Vakiener Victoria	Chief Commercial Officer	A Award deriv	2021-02-01	2021-02-02	121,754	—	$0	121,754	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award deriv	2021-02-01	2021-02-02	124,239	—	$0	124,239	SEC↗
Beaulieu Joseph	Corporate Controller	A Award deriv	2021-02-01	2021-02-02	11,550	—	$0	11,550	SEC↗
Bazemore Robert B	President & CEO	A Award deriv	2021-02-01	2021-02-02	417,443	—	$0	417,443	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award deriv	2021-02-01	2021-02-02	141,135	—	$0	141,135	SEC↗
Kutok Jeffery	Chief Scientific Officer	A Award	2021-02-01	2021-02-02	28,645	—	$0	56,057	SEC↗
Ros Matthew	See Remarks	A Award	2021-02-01	2021-02-02	28,125	—	$0	84,082	SEC↗
Vakiener Victoria	Chief Commercial Officer	A Award	2021-02-01	2021-02-02	25,520	—	$0	53,502	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award	2021-02-01	2021-02-02	26,041	—	$0	54,486	SEC↗
Beaulieu Joseph	Corporate Controller	A Award	2021-02-01	2021-02-02	7,700	—	$0	13,658	SEC↗
Bazemore Robert B	President & CEO	A Award	2021-02-01	2021-02-02	87,500	—	$0	335,867	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2021-02-01	2021-02-02	29,583	—	$0	105,310	SEC↗
Agarwal Shefali	Chief Medical Officer	S Sale	2021-01-25	2021-01-27	2,872	$11.41	$32.8K	75,727	SEC↗
Vakiener Victoria	Chief Commercial Officer	S Sale	2021-01-25	2021-01-27	599	$11.41	$6.8K	27,982	SEC↗
Ros Matthew	See Remarks	S Sale	2021-01-25	2021-01-27	2,872	$11.41	$32.8K	55,957	SEC↗
Bazemore Robert B	President & CEO	S Sale	2021-01-25	2021-01-27	6,069	$11.41	$69.2K	248,367	SEC↗
MOTT DAVID M	Director	A Award	2020-12-31	2021-01-05	2,158	$10.86	$23.4K	88,183	SEC↗
Conroy Kevin T	Director	A Award	2020-12-31	2021-01-05	1,024	$10.86	$11.1K	9,559	SEC↗
Agarwal Shefali	Chief Medical Officer	S Sale	2020-12-03	2020-12-07	2,522	$13.54	$34.1K	76,089	SEC↗
GOLDFISCHER CARL	Director	P Buy	2020-11-11	2020-11-13	5,000	$12.07	$60.4K	5,000	SEC↗
Conroy Kevin T	Director	A Award	2020-09-30	2020-10-01	933	$11.93	$11.1K	8,535	SEC↗
MOTT DAVID M	Director	A Award	2020-09-30	2020-10-01	1,965	$11.93	$23.4K	86,025	SEC↗
MOTT DAVID M	Director	A Award deriv	2020-09-22	2020-09-28	50,000	—	$0	50,000	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2020-09-02	2020-09-03	543	$12.88	$7.0K	5,958	SEC↗
Beaulieu Joseph	Corporate Controller	A Award deriv	2020-09-01	2020-09-03	6,650	—	$0	6,650	SEC↗
TOMBESI PAOLO	Chief Financial Officer	F Tax w/h	2020-08-20	2020-08-21	2,091	$12.55	$26.2K	26,906	SEC↗
TOMBESI PAOLO	Chief Financial Officer	M Exercise deriv	2020-08-19	2020-08-21	7,055	—	$0	21,162	SEC↗
TOMBESI PAOLO	Chief Financial Officer	M Exercise	2020-08-19	2020-08-21	7,055	—	$0	28,997	SEC↗
Conroy Kevin T	Director	A Award	2020-06-30	2020-07-01	693	$16.06	$11.1K	7,602	SEC↗
MOTT DAVID M	Director	A Award	2020-06-30	2020-07-01	1,459	$16.06	$23.4K	84,060	SEC↗
MOTT DAVID M	Director	P Buy	2020-06-26	2020-06-26	62,019	$16.03	$994.2K	82,601	SEC↗
Ros Matthew	See Remarks	S Sale	2020-06-26	2020-06-30	2,728	$16.15	$44.1K	57,507	SEC↗
Agarwal Shefali	Chief Medical Officer	S Sale	2020-06-26	2020-06-30	1,805	$16.15	$29.2K	78,611	SEC↗
TOMBESI PAOLO	Chief Financial Officer	S Sale	2020-06-26	2020-06-30	1,805	$16.15	$29.2K	21,942	SEC↗
Bazemore Robert B	President & CEO	S Sale	2020-06-26	2020-06-30	4,773	$16.15	$77.1K	250,098	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2020-06-26	2020-06-30	317	$16.15	$5.1K	4,838	SEC↗
Ros Matthew	See Remarks	A Award	2020-06-25	2020-06-30	6,000	—	$0	60,235	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2020-06-25	2020-06-30	6,000	—	$0	80,416	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award	2020-06-25	2020-06-30	6,000	—	$0	23,747	SEC↗
Bazemore Robert B	President & CEO	A Award	2020-06-25	2020-06-30	10,500	—	$0	254,871	SEC↗
Beaulieu Joseph	Corporate Controller	A Award	2020-06-25	2020-06-30	1,050	—	$0	5,155	SEC↗
Ros Matthew	See Remarks	M Exercise deriv	2020-06-18	2020-06-22	68,651	—	$0	104,787	SEC↗
Ros Matthew	See Remarks	M Exercise deriv	2020-06-18	2020-06-22	41,063	—	$0	110,557	SEC↗
Ros Matthew	See Remarks	M Exercise deriv	2020-06-18	2020-06-22	2,289	—	$0	107,577	SEC↗
Bazemore Robert B	President & CEO	M Exercise deriv	2020-06-18	2020-06-22	10,000	—	$0	323,333	SEC↗
Ros Matthew	See Remarks	S Sale	2020-06-18	2020-06-22	41,063	$20.50	$841.8K	51,798	SEC↗
Ros Matthew	See Remarks	M Exercise	2020-06-18	2020-06-22	68,651	$9.58	$657.7K	120,449	SEC↗
Ros Matthew	See Remarks	S Sale	2020-06-18	2020-06-22	2,289	$22.00	$50.4K	51,798	SEC↗
Ros Matthew	See Remarks	M Exercise	2020-06-18	2020-06-22	2,289	$12.45	$28.5K	54,087	SEC↗
Ros Matthew	See Remarks	M Exercise	2020-06-18	2020-06-22	41,063	$9.12	$374.5K	92,861	SEC↗
Ros Matthew	See Remarks	S Sale	2020-06-18	2020-06-22	68,651	$21.65	$1.49M	51,798	SEC↗
Bazemore Robert B	President & CEO	S Sale	2020-06-18	2020-06-22	10,000	$22.00	$220.0K	244,371	SEC↗
Bazemore Robert B	President & CEO	M Exercise	2020-06-18	2020-06-22	10,000	$8.98	$89.8K	264,371	SEC↗
Bazemore Robert B	President & CEO	S Sale	2020-06-18	2020-06-22	10,000	$22.00	$220.0K	254,371	SEC↗
MOTT DAVID M	Director	J Other	2020-06-18	2020-06-22	67,662	—	$0	106,959	SEC↗
BATE KENNETH	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
MOTT DAVID M	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
POPS RICHARD F	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
GOLDFISCHER CARL	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
Bogle Grant C.	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
Conroy Kevin T	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
Richon Victoria	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
Allen Andrew R	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
Giordano Michael F	Director	A Award deriv	2020-05-29	2020-06-02	14,013	—	$0	14,013	SEC↗
Legorreta Pablo G.	Director, 10% Owner	A Award deriv	2020-05-29	2020-06-02	14,103	—	$0	14,103	SEC↗
Kutok Jeffery	Chief Scientific Officer	A Award deriv	2020-04-01	2020-04-03	131,580	—	$0	131,580	SEC↗
Kutok Jeffery	Chief Scientific Officer	A Award	2020-04-01	2020-04-03	27,412	—	$0	27,412	SEC↗
Conroy Kevin T	Director	A Award	2020-03-31	2020-04-02	717	$15.51	$11.1K	6,909	SEC↗
MOTT DAVID M	Director	A Award	2020-03-31	2020-04-02	1,512	$15.51	$23.5K	20,582	SEC↗
Agarwal Shefali	Chief Medical Officer	S Sale	2020-03-25	2020-03-26	1,243	$15.28	$19.0K	71,991	SEC↗
Bazemore Robert B	President & CEO	S Sale	2020-03-25	2020-03-26	3,285	$15.28	$50.2K	254,371	SEC↗
Ros Matthew	See Remarks	S Sale	2020-03-25	2020-03-26	1,243	$15.28	$19.0K	51,798	SEC↗
TOMBESI PAOLO	Chief Financial Officer	S Sale	2020-03-25	2020-03-26	1,243	$15.28	$19.0K	15,437	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2020-03-25	2020-03-26	212	$15.28	$3.2K	4,961	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award	2020-03-24	2020-06-30	4,000	—	$0	17,747	SEC↗
Ros Matthew	See Remarks	A Award	2020-03-24	2020-06-30	4,000	—	$0	54,235	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2020-03-24	2020-06-30	4,000	—	$0	74,416	SEC↗
Beaulieu Joseph	Corporate Controller	A Award	2020-03-24	2020-06-30	700	—	$0	4,105	SEC↗
Bazemore Robert B	President & CEO	J Other deriv	2020-03-24	2020-03-26	79,167	—	$0	333,333	SEC↗
Bazemore Robert B	President & CEO	A Award deriv	2020-03-24	2020-03-26	73,409	—	$0	73,409	SEC↗
Bazemore Robert B	President & CEO	J Other deriv	2020-03-24	2020-03-26	2,371	—	$0	333,333	SEC↗
Bazemore Robert B	President & CEO	J Other deriv	2020-03-24	2020-03-26	48,727	—	$0	298,737	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2020-03-24	2020-03-26	1,575	—	$0	73,234	SEC↗
Bazemore Robert B	President & CEO	A Award	2020-03-24	2020-03-26	113,393	—	$0	250,656	SEC↗
Bazemore Robert B	President & CEO	J Other	2020-03-24	2020-03-26	56,537	—	$0	80,726	SEC↗
Bazemore Robert B	President & CEO	A Award	2020-03-24	2020-03-26	7,000	—	$0	257,656	SEC↗
Ros Matthew	See Remarks	A Award	2020-03-24	2020-03-26	1,563	—	$0	53,041	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award	2020-03-24	2020-03-26	1,690	—	$0	16,680	SEC↗
Beaulieu Joseph	Corporate Controller	A Award	2020-03-24	2020-03-26	1,556	—	$0	5,173	SEC↗
Allen Andrew R	Director	M Exercise deriv	2020-03-16	2020-03-18	12,500	—	$0	0	SEC↗
Allen Andrew R	Director	M Exercise	2020-03-16	2020-03-18	12,500	$9.33	$116.6K	12,500	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2020-03-03	2020-03-05	996	$22.18	$22.1K	3,617	SEC↗
RP Management, LLC	Director, 10% Owner	A Award	2020-02-11	2020-02-13	2,500,000	$20.00	$50.00M	9,166,667	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award deriv	2020-02-03	2020-02-05	56,213	—	$0	56,213	SEC↗
Beaulieu Joseph	Corporate Controller	A Award deriv	2020-02-03	2020-02-05	11,588	—	$0	11,588	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award deriv	2020-02-03	2020-02-05	61,834	—	$0	61,834	SEC↗
Ros Matthew	See Remarks	A Award deriv	2020-02-03	2020-02-05	56,213	—	$0	56,213	SEC↗
Bazemore Robert B	President & CEO	A Award deriv	2020-02-03	2020-02-05	252,956	—	$0	252,956	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award	2020-02-03	2020-02-05	11,688	—	$0	14,990	SEC↗
Beaulieu Joseph	Corporate Controller	A Award	2020-02-03	2020-02-05	2,575	—	$0	3,617	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2020-02-03	2020-02-05	12,856	—	$0	71,659	SEC↗
Ros Matthew	See Remarks	A Award	2020-02-03	2020-02-05	11,688	—	$0	51,478	SEC↗
Bazemore Robert B	President & CEO	A Award	2020-02-03	2020-02-05	52,595	—	$0	137,263	SEC↗
Bazemore Robert B	President & CEO	S Sale	2020-01-27	2020-01-27	6,074	$20.44	$124.2K	84,668	SEC↗
Agarwal Shefali	Chief Medical Officer	S Sale	2020-01-27	2020-01-27	2,630	$20.44	$53.8K	58,803	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2020-01-24	2020-01-27	330	$24.63	$8.1K	1,042	SEC↗
Bazemore Robert B	President & CEO	S Sale	2020-01-24	2020-01-27	3,002	$24.62	$73.9K	90,742	SEC↗
Ros Matthew	See Remarks	F Tax w/h	2020-01-24	2020-01-27	2,395	$22.40	$53.6K	39,790	SEC↗
Ros Matthew	See Remarks	S Sale	2020-01-24	2020-01-27	1,847	$24.64	$45.5K	42,185	SEC↗
Agarwal Shefali	Chief Medical Officer	S Sale	2020-01-24	2020-01-27	1,843	$24.64	$45.4K	61,433	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award	2020-01-23	2020-01-27	5,000	—	$0	5,000	SEC↗
TOMBESI PAOLO	Chief Financial Officer	F Tax w/h	2020-01-23	2020-01-27	1,698	$26.72	$45.4K	3,302	SEC↗
Beaulieu Joseph	Corporate Controller	A Award	2020-01-23	2020-01-27	875	—	$0	1,372	SEC↗
Bazemore Robert B	President & CEO	A Award	2020-01-23	2020-01-27	8,750	—	$0	93,744	SEC↗
Ros Matthew	See Remarks	A Award	2020-01-23	2020-01-27	5,000	—	$0	44,032	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2020-01-23	2020-01-27	5,000	—	$0	63,276	SEC↗
Conroy Kevin T	Director	A Award	2019-12-31	2020-01-03	452	$24.60	$11.1K	6,192	SEC↗
MOTT DAVID M	Director	A Award	2019-12-31	2020-01-03	952	$24.60	$23.4K	19,070	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award deriv	2019-12-02	2020-01-07	34,978	—	$0	34,978	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2019-12-02	2020-01-07	22,577	—	$0	58,276	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award deriv	2019-12-02	2019-12-06	34,978	—	$0	34,978	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2019-12-02	2019-12-06	22,577	—	$0	58,276	SEC↗
Legorreta Pablo G.	Director	A Award deriv	2019-11-06	2019-11-08	34,408	—	$0	34,408	SEC↗
Conroy Kevin T	Director	A Award	2019-09-30	2019-10-02	1,078	$10.32	$11.1K	5,740	SEC↗
MOTT DAVID M	Director	A Award	2019-09-30	2019-10-02	2,271	$10.32	$23.4K	18,118	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2019-09-03	2020-09-03	971	$12.77	$12.4K	6,501	SEC↗
Richon Victoria	Director	A Award deriv	2019-09-02	2019-09-04	37,075	—	$0	37,075	SEC↗
Bogle Grant C.	Director	A Award deriv	2019-09-02	2019-09-04	37,075	—	$0	37,075	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award deriv	2019-08-19	2019-08-21	132,225	—	$0	132,225	SEC↗
TOMBESI PAOLO	Chief Financial Officer	A Award deriv	2019-08-19	2019-08-21	28,217	—	$0	28,217	SEC↗
Conroy Kevin T	Director	A Award	2019-06-30	2019-07-02	887	$12.55	$11.1K	4,662	SEC↗
SEIDENBERG BETH C	Director	A Award	2019-06-30	2019-07-02	1,010	$12.55	$12.7K	8,481	SEC↗
MOTT DAVID M	Director	A Award	2019-06-30	2019-07-02	1,868	$12.55	$23.4K	15,847	SEC↗
MOTT DAVID M	Director	S Sale	2019-06-27	2019-06-28	52,473	$12.43	$652.2K	0	SEC↗
MOTT DAVID M	Director	S Sale	2019-06-26	2019-06-26	52,472	$12.85	$674.3K	52,473	SEC↗
MOTT DAVID M	Director	S Sale	2019-06-25	2019-06-26	52,472	$13.31	$698.4K	104,945	SEC↗
MOTT DAVID M	Director	J Other	2019-06-24	2019-09-11	165,919	—	$0	8,502	SEC↗
MOTT DAVID M	Director	J Other	2019-06-24	2019-06-26	38,646	—	$0	39,297	SEC↗
MOTT DAVID M	Director	J Other	2019-06-24	2019-06-26	157,417	—	$0	157,417	SEC↗
MOTT DAVID M	Director	J Other	2019-06-24	2019-06-26	767,500	—	$0	0	SEC↗
MOTT DAVID M	Director	J Other	2019-06-24	2019-06-26	767,500	—	$0	767,500	SEC↗
MOTT DAVID M	Director	J Other	2019-06-24	2019-06-26	2,500,000	—	$0	3,971,018	SEC↗
Agarwal Shefali	Chief Medical Officer	S Sale	2019-06-14	2019-06-17	1,195	$11.97	$14.3K	35,699	SEC↗
Bazemore Robert B	President & CEO	S Sale	2019-06-13	2019-06-14	2,074	$12.10	$25.1K	84,994	SEC↗
Ros Matthew	See Remarks	S Sale	2019-06-13	2019-06-14	1,185	$12.10	$14.3K	39,032	SEC↗
Beaulieu Joseph	Corporate Controller	S Sale	2019-06-13	2019-06-14	203	$12.10	$2.5K	497	SEC↗
Bazemore Robert B	President & CEO	A Award	2019-06-12	2019-06-14	7,000	—	$0	87,068	SEC↗
Ros Matthew	See Remarks	A Award	2019-06-12	2019-06-14	4,000	—	$0	40,217	SEC↗
Agarwal Shefali	Chief Medical Officer	A Award	2019-06-12	2019-06-14	4,000	—	$0	36,894	SEC↗
Beaulieu Joseph	Corporate Controller	A Award	2019-06-12	2019-06-14	700	—	$0	700	SEC↗
POPS RICHARD F	Director	A Award deriv	2019-05-31	2019-06-07	17,633	—	$0	17,633	SEC↗
Giordano Michael F	Director	A Award deriv	2019-05-31	2019-06-07	17,633	—	$0	17,633	SEC↗
Conroy Kevin T	Director	A Award deriv	2019-05-31	2019-06-07	17,633	—	$0	17,633	SEC↗
Allen Andrew R	Director	A Award deriv	2019-05-31	2019-06-07	17,633	—	$0	17,633	SEC↗
BATE KENNETH	Director	A Award deriv	2019-05-31	2019-06-07	17,633	—	$0	17,633	SEC↗
GOLDFISCHER CARL	Director	A Award deriv	2019-05-31	2019-06-07	17,633	—	$0	17,633	SEC↗
SEIDENBERG BETH C	Director	A Award deriv	2019-05-31	2019-06-07	17,633	—	$0	17,633	SEC↗
MOTT DAVID M	Director	A Award deriv	2019-05-31	2019-06-07	17,633	—	$0	17,633	SEC↗